Welcome to LookChem.com Sign In|Join Free
  • or
cis-4-tert-Butyldimethylsilyloxycyclohexanol is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

103202-62-6

Post Buying Request

103202-62-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

103202-62-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 103202-62-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,3,2,0 and 2 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 103202-62:
(8*1)+(7*0)+(6*3)+(5*2)+(4*0)+(3*2)+(2*6)+(1*2)=56
56 % 10 = 6
So 103202-62-6 is a valid CAS Registry Number.

103202-62-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name cis-4-((tert-butyl(dimethyl)silyl)oxy)cyclohexanol

1.2 Other means of identification

Product number -
Other names cis-4-(tert-butyldimethylsilyloxy)-cyclohexanol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:103202-62-6 SDS

103202-62-6Relevant academic research and scientific papers

Synthesis and immunological evaluation of a low molecular weight saccharide with TLR-4 agonist activity

Basava, Vikram,Romlein, Heather,Bitsaktsis, Constantine,Marzabadi, Cecilia H.

, p. 697 - 705 (2017/01/03)

The paucity of FDA approved adjuvants renders the synthesis, characterization, and use of new compounds as vaccine adjuvants, a necessity. For this purpose, a novel saccharide analog has been synthesized from glucosamine, pyruvylated galactose and 1,4-cyclohexanediol and its biological efficacy was determined in innate immune cells. More specifically, we assessed the production of pro-inflammatory cytokines from the murine monocyte cell line, Raw 264.7 and from C57 BL/6 mouse peritoneal macrophages following exposure to the saccharide analog. Our data conclude that the novel saccharide has immunostimulatory activity on mouse macrophages as indicated by the elevated levels of IL-6 and TNF-α in culture supernatants. This effect was TLR-4-dependent but TLR-2-independent. Our data, suggest TLR-4 agonism; a key feature of vaccine adjuvants.

HETEROCYCLIC COMPOUND

-

Paragraph 0493, (2015/04/15)

The present invention provides a compound having a superior JAK inhibitory action, which is useful as an agent for the prophylaxis or treatment of autoimmune diseases (rheumatoid arthritis, psoriasis, inflammatory bowel disease, Sjogren's syndrome, Behcet's disease, multiple sclerosis, systemic lupus erythematosus, etc.), cancer (leukemia, uterine leiomyosarcoma, prostate cancer, multiple myeloma, cachexia, myelofibrosis, etc.) and the like, or a salt thereof. The present invention relates to a compound represented by the formula wherein each symbol is as defined in the specification, or a salt thereof.

Hexanes/acetonitrile: A binary solvent system for the efficient monosilylation of symmetric primary and secondary diols

Wilke, Burkhardt I.,Dornan, Mark H.,Yeung, Jon,Boddy, Christopher N.,Pinto, Atahualpa

, p. 2600 - 2602 (2014/05/06)

Symmetric diols are useful compounds in the synthesis of natural products, their value often dependent on their successful monoprotection. A general and simple method for the monosilylation of symmetrical primary and secondary diols is reported. The metho

SPIROINDOLINONE DERIVATIVES

-

Page/Page column 76, (2009/07/03)

There are provided compounds of the formula and pharmaceutically acceptable salts and esters thereof wherein W, V, X, Y, A, R and R' are as described herein. The compounds are useful as anticancer agents.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 103202-62-6